Bill > S1346

This bill, titled the "Maintaining Idaho Children's Health Act," establishes a two-year moratorium in Idaho on the administration of certain human gene therapy products, which are defined as products that work by altering genetic material, to children under eighteen years old and pregnant women, regardless of whether they are called immunizations or vaccines. The Legislature's intent is to protect these vulnerable populations from experimental gene therapy and biologic products used as immunizations, citing concerns about reported adverse events and unknown long-term consequences, and aims to fill a perceived gap in regulatory protection. However, this moratorium does not apply to human gene therapy products used for the treatment of cancer or genetic disorders, and specific exemptions can be granted if a product is proven safe with proper informed consent and compensation for adverse outcomes, is part of an approved clinical trial, or is provided under compassionate use for life-threatening conditions. The bill also declares an emergency, meaning it will take effect immediately upon passage and approval.

Health and Social Services, Justice

Judiciary and Rules Committee (Senate)

https://legislature.idaho.gov/sessioninfo/2026/legislation/S1346/